At consensus peak sales of $2B for the Parkinson's market alone (not counting Alz or other future possible sales), ACAD trades at only P/S = 2. That's extremely cheap for biotechs. And with the safety and efficacy profile it has, and the selloff before the announcement into the 30's, this is a strong "buy" right here. Never mind it might go down another half point or so into the close, due to risk-off before China opens again. At least, you should all be nibbling as it edges lower today. The short-bashers out there are just trying to get your shares cheap - don't be a sucker.
I'd have thought the stock would be UP today, given the vote of confidence this is a solid, real company by a major global bank, and given the sweetener for warrants exercisable at a price 20% higher than right now. So yeah, this makes no sense to me. Buy more.
Today pullback may be some big money trying to drive it down so they can pick up shares before tomorrow.
there's 27 million shares outstanding - so we're talking about a dilution of 0.04% !! It's nothing. Stop your ranting. Buy the dip. Shorts are scared of a squeeze - looks like that's you too.
BMY has made/signed the deal. All FPRX has to do is what they do best - make outstanding therapies. Look at the royalties alone ("double digit") and it makes the current market cap today look small. Yes, 60% is a lot to do in one day, so there'll be profit-takers perhaps going right into the close. Nibble on any pullbacks that result. This will go higher, and it might be too late tomorrow, after Cramer talks about it.
the Market cap is still only $700M, and the deal is far more than this - I think this has a ways more to go. There's some headwind with profit taking by the faithful who held through this annoucement, so maybe scale in. ....
I bought this because of the low risk, new orphan drug designation, and low PE. The low float makes it both an opportunity and a danger. However, it looks like it's just successfully double-bottomed off the 137 level and the points of jrrhenderson662 are excellent. I can't see any reason in the news for why it had a worse day than BIB or the other biotechs in general, other than the low float and someone wanted out. It should bounce back at least to the high 140's.
Do they go to Utility Scale facilities, or rooftops? If the latter, the SCTY spillover may explain at least the movement - but even then, SCTY is down because they don't have a defendable monopoly on their business model, and they're losing share. So these knee-jerk selloffs are just a buying opportunity. Note that oil is stable, and nat gas is rising today.
neither the buying nor the selling of the past hour had any real volume. Yesterday's announcement of the Nov 4 ER didn't hurt the stock, and I expect a positive ER in any event. This looks like pure market makers toying with a stock they want more of, and has a small float and daily volume so they can whack at it effectively. I bought a bit more today.
Sentiment: Strong Buy
PEG of 0.23!? /NG natural gas rocketing UP today, which has the highest correlation with solar competition, This valuation just doesn't make any sense. It's already successfully tested the 25's. China has been vocal about heading off revolution from smog-infuriated citizens by going solar/wind. Anyone got an actual believable reason why this should be down 4% today? I'm tempted to load up.
provide a link, or be dismissed as just another shorty pumper